BBBS Holds First Ever Celebration of Mentoring Night


Big Brothers Big Sisters pic

Big Brothers Big Sisters

In his role as managing partner and head of capital markets at New York City-based Laidlaw & Company, James “Jimmy” Ahern has led the firm to strong growth in the health care investment sector. Active in his local community, one of the ways James “Jim” Ahern gives back is by serving on the board of overseers with Big Brothers Big Sisters (BBBS) of Massachusetts Bay when he isn’t working at Laidlaw.

Last January at Cape Cod Beer, Big Brothers Big Sisters of Massachusetts recently held its inaugural Celebration of Mentoring event. More than 100 mentors, BBBS advocates, and local leaders turned out to celebrate the occasion, which consisted of an evening of raffle drawings, dinner, and gaming.

The big winner on the night was Mary Marsters, whose raffle ticket was chosen in the grand prize drawing. She won tickets to attend a Boston Red Sox game and stay at the famous Hotel Commonwealth. Overall, the event was able to raise $1,200 in support of BBBS programs.

Benefits and Uses of Biotechnology


James “Jim” Ahern possesses over a decade of experience as a financial executive in the investing industry, assuming roles such as vice president and managing director. Currently, James Ahern serves as managing partner and head of capital markets for New York-based Laidlaw and Company. At Laidlaw, he is involved in life sciences investment banking and biotechnology investment banking among other duties.

Defined as a form of technology based on biology, biotechnology has been used for many years for the production and preservation of food products such as dairy. Biotechnology, which employs processes at the cellular and bimolecular level, offers a range of benefits which include:

– Improving health outcomes by using the human genetic makeup to advance research and medicine.
– Improving the efficiency of global manufacturing and energy consumption, while also reducing waste and the reliance on petrochemicals.
– Improving crop outcomes to produce more food on a global scale, including production of biotech crops that meet specific needs and reducing the need for added chemicals and pesticides.